Symbols / EVFM
EVFM Chart
About
Evofem Biosciences, Inc., a biopharmaceutical company, develops and commercializes various products to address unmet needs in women's sexual and reproductive health. The company's commercial products include PHEXXI, a vaginal gel for the prevention of pregnancy; and SOLOSEC, a single-dose oral antimicrobial agent for the treatment of bacterial vaginosis and trichomoniasis. Evofem Biosciences, Inc. is headquartered in San Diego, California.
Fundamentals
Scroll to Statements| Sector | Healthcare | Industry | Biotechnology | Market Cap | 1.04M |
| Enterprise Value | 58.02M | Income | -5.55M | Sales | 17.73M |
| Book/sh | -0.61 | Cash/sh | 0.00 | Dividend Yield | — |
| Payout | 0.00% | Employees | 32 | IPO | — |
| P/E | — | Forward P/E | -0.01 | PEG | — |
| P/S | 0.06 | P/B | -0.01 | P/C | — |
| EV/EBITDA | -26.84 | EV/Sales | 3.27 | Quick Ratio | 0.06 |
| Current Ratio | 0.10 | Debt/Eq | — | LT Debt/Eq | — |
| EPS (ttm) | -0.05 | EPS next Y | -0.55 | EPS Growth | — |
| Revenue Growth | 10.10% | Earnings | 2024-03-27 08:00 | ROA | -9.63% |
| ROE | — | ROIC | — | Gross Margin | 80.05% |
| Oper. Margin | -19.83% | Profit Margin | -30.66% | Shs Outstand | 126.69M |
| Shs Float | 126.68M | Short Float | 11.01% | Short Ratio | 0.19 |
| Short Interest | — | 52W High | 0.02 | 52W Low | 0.01 |
| Beta | -1.37 | Avg Volume | 302.79K | Volume | 8.00 |
| Target Price | — | Recom | None | Prev Close | $0.01 |
| Price | $0.01 | Change | -10.87% |
Valuation Models
Price estimates from analyst targets and simple models.
1. Analyst consensus
—
Mean price target
2. Current target
$0.01
Latest analyst target
3. DCF / Fair value
$-1.02
Simplified: (Free Cash Flow ÷ Shares) × 18 (P/FCF multiple). Not a …
Ratings
Current target
$0.01
Low
—
High
—
Mean
—
- Evofem (OTC: EVFM) stockholders reject Aditxt merger; ends deal, pursues national listing - Stock Titan Mon, 20 Oct 2025 07
- Evofem Anticipates Approval of Merger with Aditxt at Upcoming Stockholder Meeting - Yahoo Finance ue, 09 Sep 2025 07
- Aditxt shareholders approve board re-election and reverse stock split authority - Investing.com Wed, 24 Sep 2025 07
- Evofem Secures Investor Support for Proposed Merger through Voting Agreements - PR Newswire Wed, 06 Nov 2024 08
- Evofem anticipates approval of merger with Aditxt at upcoming meeting - Investing.com ue, 09 Sep 2025 07
- Why Evofem Biosciences Is Down Today - The Motley Fool Wed, 03 Jun 2020 07
- Evofem Biosciences (EVFM) Stock Remains in Spotlight With Contraception Access Deal - InvestorPlace ue, 28 Jun 2022 07
- Evofem Biosciences Announces 1-for-125 Reverse Stock Split - PR Newswire Wed, 17 May 2023 07
- Evofem Acquired by Aditxt for $100M - San Diego Business Journal Mon, 01 Jan 2024 08
- Aditxt To Acquire Evofem For $100 Mln; ADTX Stock Soar - Nasdaq ue, 12 Dec 2023 08
- Aditxt and Evofem Seek Approval for Merger, Closing Expected Q4 2024 - Stocktwits Mon, 30 Sep 2024 21
- Tiny birth control stock soars following Roe v. Wade overturn - CNN hu, 28 Jul 2022 07
- Evofem faces delisting as stock price falls below $0.01 - Investing.com Fri, 30 Aug 2024 07
- Why Is Endo International (ENDP) Stock Up 90% Today? - InvestorPlace ue, 28 Jun 2022 07
- 2 Contraceptive Stocks That Could Benefit From Roe v. Wade Reversal - Yahoo Finance ue, 28 Jun 2022 07
Insider Transactions
No recent insider transactions.
Financials
| Line Item | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|
| TaxEffectOfUnusualItems | 0.00 | 7.34K | 1.99M | -9.09M |
| TaxRateForCalcs | 0.00 | 0.00 | 0.21 | 0.27 |
| NormalizedEBITDA | -8.29M | -89.51M | -91.55M | -132.12M |
| TotalUnusualItems | 1.38M | 73.44M | 9.47M | -33.66M |
| TotalUnusualItemsExcludingGoodwill | 1.38M | 73.44M | 9.47M | -33.66M |
| NetIncomeFromContinuingOperationNetMinorityInterest | -8.86M | 52.98M | -76.70M | -205.19M |
| ReconciledDepreciation | 756.00K | 1.78M | 2.05M | 1.02M |
| ReconciledCostOfRevenue | 3.70M | 4.73M | 4.42M | 4.05M |
| EBITDA | -6.92M | -16.07M | -82.08M | -165.78M |
| EBIT | -7.68M | -17.85M | -84.12M | -166.80M |
| NetInterestIncome | 16.00K | 31.00K | 85.00K | 15.00K |
| InterestIncome | 16.00K | 31.00K | 85.00K | 15.00K |
| NormalizedIncome | -10.23M | -20.45M | -84.18M | -180.62M |
| NetIncomeFromContinuingAndDiscontinuedOperation | -8.86M | 52.98M | -76.70M | -205.19M |
| TotalExpenses | 27.04M | 36.06M | 100.96M | 175.04M |
| TotalOperatingIncomeAsReported | -7.68M | -17.85M | -84.12M | -166.80M |
| DilutedAverageShares | 75.20M | 984.04M | 465.98K | 69.82K |
| BasicAverageShares | 75.20M | 4.83M | 465.98K | 69.82K |
| DilutedEPS | -0.12 | 0.05 | -167.50 | -2.96K |
| BasicEPS | -0.12 | 10.36 | -167.50 | -2.96K |
| DilutedNIAvailtoComStockholders | -8.96M | 49.99M | -78.01M | -206.24M |
| NetIncomeCommonStockholders | -8.96M | 49.99M | -78.01M | -206.24M |
| PreferredStockDividends | 105.00K | 2.98M | 1.32M | 1.05M |
| NetIncome | -8.86M | 52.98M | -76.70M | -205.19M |
| NetIncomeIncludingNoncontrollingInterests | -8.86M | 52.98M | -76.70M | -205.19M |
| NetIncomeContinuousOperations | -8.86M | 52.98M | -76.70M | -205.19M |
| TaxProvision | 0.00 | 17.00K | 44.00K | 17.00K |
| PretaxIncome | -8.86M | 53.00M | -76.65M | -205.18M |
| OtherIncomeExpense | -1.20M | 70.81M | 7.38M | -38.39M |
| OtherNonOperatingIncomeExpenses | -2.58M | -2.63M | -2.09M | -4.73M |
| SpecialIncomeCharges | 977.00K | 75.34M | -24.49M | |
| OtherSpecialCharges | -977.00K | -75.34M | 24.49M | |
| GainOnSaleOfSecurity | 398.00K | -1.90M | 33.96M | -33.66M |
| NetNonOperatingInterestIncomeExpense | 16.00K | 31.00K | 85.00K | 15.00K |
| InterestIncomeNonOperating | 16.00K | 31.00K | 85.00K | 15.00K |
| OperatingIncome | -7.68M | -17.85M | -84.12M | -166.80M |
| OperatingExpense | 23.20M | 29.55M | 96.55M | 170.99M |
| DepreciationAmortizationDepletionIncomeStatement | 619.00K | 0.00 | ||
| DepreciationAndAmortizationInIncomeStatement | 619.00K | 0.00 | ||
| Amortization | 619.00K | 0.00 | ||
| AmortizationOfIntangiblesIncomeStatement | 619.00K | 0.00 | ||
| ResearchAndDevelopment | 1.84M | 2.94M | 25.03M | 33.13M |
| SellingGeneralAndAdministration | 20.74M | 26.61M | 71.51M | 137.86M |
| SellingAndMarketingExpense | 9.18M | 11.66M | 43.95M | 113.15M |
| GeneralAndAdministrativeExpense | 11.56M | 14.95M | 27.56M | 24.71M |
| OtherGandA | 11.56M | 14.95M | 27.56M | 24.71M |
| GrossProfit | 15.53M | 11.71M | 12.42M | 4.19M |
| CostOfRevenue | 3.83M | 6.51M | 4.42M | 4.05M |
| TotalRevenue | 19.36M | 18.22M | 16.84M | 8.24M |
| OperatingRevenue | 19.36M | 18.22M | 16.84M | 8.24M |
| Line Item | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|
| OrdinarySharesNumber | 113.36M | 20.01M | 984.79K | 86.67K |
| ShareIssued | 113.36M | 20.01M | 984.79K | 86.67K |
| NetDebt | 45.88M | 43.27M | 62.91M | 101.19M |
| TotalDebt | 45.97M | 43.37M | 71.13M | 115.68M |
| TangibleBookValue | -80.85M | -66.51M | -71.80M | -104.31M |
| InvestedCapital | -25.38M | -23.24M | -6.12M | 4.61M |
| WorkingCapital | -66.84M | -63.25M | -81.13M | -107.52M |
| NetTangibleAssets | -80.85M | -66.51M | -71.80M | -99.58M |
| CapitalLeaseObligations | 89.00K | 105.00K | 5.44M | 6.76M |
| CommonStockEquity | -71.26M | -66.51M | -71.80M | -104.31M |
| PreferredStockEquity | 4.74M | |||
| TotalCapitalization | -71.26M | -66.51M | -71.80M | -99.58M |
| TotalEquityGrossMinorityInterest | -71.26M | -66.51M | -71.80M | -99.58M |
| StockholdersEquity | -71.26M | -66.51M | -71.80M | -99.58M |
| GainsLossesNotAffectingRetainedEarnings | -2.63M | -849.00K | 49.53M | 5.09M |
| OtherEquityAdjustments | -2.63M | -849.00K | 49.53M | 5.09M |
| RetainedEarnings | -897.66M | -888.70M | -938.69M | -860.68M |
| AdditionalPaidInCapital | 829.03M | 823.04M | 817.37M | 751.26M |
| CapitalStock | 11.00K | 2.00K | 0.00 | 4.76M |
| CommonStock | 11.00K | 2.00K | 0.00 | 16.00K |
| PreferredStock | 0.00 | 0.00 | 0.00 | 4.74M |
| TotalLiabilitiesNetMinorityInterest | 95.05M | 77.06M | 96.96M | 142.09M |
| TotalNonCurrentLiabilitiesNetMinorityInterest | 14.60M | 4.60M | 3.13M | 4.42M |
| OtherNonCurrentLiabilities | 9.81M | |||
| PreferredSecuritiesOutsideStockEquity | 4.78M | 4.59M | 0.00 | 0.00 |
| LongTermDebtAndCapitalLeaseObligation | 7.00K | 8.00K | 3.13M | 4.42M |
| LongTermCapitalLeaseObligation | 7.00K | 8.00K | 3.13M | 4.42M |
| CurrentLiabilities | 80.45M | 72.46M | 93.83M | 137.66M |
| OtherCurrentLiabilities | 9.31M | 5.24M | 4.55M | 3.07M |
| CurrentDebtAndCapitalLeaseObligation | 45.96M | 43.37M | 68.00M | 111.26M |
| CurrentCapitalLeaseObligation | 82.00K | 97.00K | 2.31M | 2.33M |
| CurrentDebt | 45.88M | 43.27M | 65.68M | 108.93M |
| OtherCurrentBorrowings | 45.88M | 43.27M | 65.68M | 108.93M |
| PensionandOtherPostRetirementBenefitPlansCurrent | 3.49M | 2.61M | 2.17M | 4.65M |
| PayablesAndAccruedExpenses | 21.68M | 21.25M | 19.11M | 18.69M |
| CurrentAccruedExpenses | 5.51M | 4.23M | 4.12M | 8.37M |
| Payables | 16.17M | 17.02M | 14.98M | 10.32M |
| AccountsPayable | 16.17M | 17.02M | 14.98M | 10.32M |
| TotalAssets | 23.79M | 10.55M | 25.16M | 42.51M |
| TotalNonCurrentAssets | 10.18M | 1.34M | 12.46M | 12.37M |
| OtherNonCurrentAssets | 36.00K | 35.00K | 2.40M | 1.09M |
| NonCurrentPrepaidAssets | 0.00 | 1.72M | 109.00K | |
| GoodwillAndOtherIntangibleAssets | 9.60M | 0.00 | ||
| OtherIntangibleAssets | 9.60M | |||
| NetPPE | 547.00K | 1.31M | 8.35M | 11.17M |
| AccumulatedDepreciation | -701.00K | -1.19M | -3.19M | -2.17M |
| GrossPPE | 1.25M | 2.50M | 11.54M | 13.34M |
| Leases | 0.00 | 3.39M | 3.39M | |
| ConstructionInProgress | 429.00K | 1.16M | 1.57M | 2.41M |
| OtherProperties | 674.00K | 692.00K | 5.06M | 6.05M |
| MachineryFurnitureEquipment | 145.00K | 647.00K | 1.52M | 1.50M |
| Properties | 0.00 | 0.00 | 0.00 | |
| CurrentAssets | 13.61M | 9.21M | 12.70M | 30.14M |
| OtherCurrentAssets | 1.33M | 1.12M | 2.22M | 1.77M |
| RestrictedCash | 741.00K | 580.00K | 1.21M | 5.06M |
| PrepaidAssets | 127.00K | 76.00K | 1.79M | 1.46M |
| Inventory | 1.58M | 1.70M | 5.38M | 7.67M |
| FinishedGoods | 245.00K | 791.00K | ||
| WorkInProcess | 982.00K | 386.00K | ||
| RawMaterials | 350.00K | 520.00K | ||
| Receivables | 9.83M | 5.74M | 1.13M | 6.45M |
| NotesReceivable | 0.00 | |||
| AccountsReceivable | 9.83M | 5.74M | 1.13M | 6.45M |
| CashCashEquivalentsAndShortTermInvestments | 0.00 | 0.00 | 2.77M | 7.73M |
| CashAndCashEquivalents | 0.00 | 0.00 | 2.77M | 7.73M |
| Line Item | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|
| FreeCashFlow | -3.90M | -8.97M | -70.75M | -149.61M |
| RepurchaseOfCapitalStock | 0.00 | -18.00K | 0.00 | |
| RepaymentOfDebt | -782.00K | -1.15M | -5.89M | 0.00 |
| IssuanceOfDebt | 397.00K | 5.64M | 11.50M | 0.00 |
| IssuanceOfCapitalStock | 5.00M | 0.00 | 32.32M | 91.53M |
| CapitalExpenditure | -14.00K | -4.00K | -341.00K | -2.94M |
| InterestPaidSupplementalData | 159.00K | 338.00K | 698.00K | 1.39M |
| IncomeTaxPaidSupplementalData | 8.00K | 4.00K | 26.00K | 11.00K |
| EndCashPosition | 741.00K | 580.00K | 4.78M | 13.59M |
| BeginningCashPosition | 580.00K | 4.78M | 13.59M | 72.25M |
| ChangesInCash | 161.00K | -4.20M | -8.81M | -58.66M |
| FinancingCashFlow | 4.62M | 4.78M | 61.94M | 90.69M |
| CashFlowFromContinuingFinancingActivities | 4.62M | 4.78M | 61.94M | 90.69M |
| NetOtherFinancingCharges | -1.20M | -1.30M | ||
| ProceedsFromStockOptionExercised | 0.00 | 290.00K | 25.23M | 456.00K |
| NetPreferredStockIssuance | 0.00 | 10.00M | ||
| PreferredStockIssuance | 0.00 | 10.00M | ||
| NetCommonStockIssuance | 5.00M | 0.00 | 32.30M | 81.53M |
| CommonStockPayments | 0.00 | -18.00K | 0.00 | |
| CommonStockIssuance | 5.00M | 0.00 | 32.32M | 81.53M |
| NetIssuancePaymentsOfDebt | -385.00K | 4.49M | 5.61M | 0.00 |
| NetShortTermDebtIssuance | -385.00K | 4.49M | ||
| ShortTermDebtPayments | -782.00K | -1.15M | ||
| ShortTermDebtIssuance | 397.00K | 5.64M | ||
| NetLongTermDebtIssuance | 4.49M | 5.61M | 0.00 | |
| LongTermDebtPayments | -1.15M | -5.89M | 0.00 | |
| LongTermDebtIssuance | 5.64M | 11.50M | 0.00 | |
| InvestingCashFlow | -569.00K | -4.00K | -341.00K | -2.69M |
| CashFlowFromContinuingInvestingActivities | -569.00K | -4.00K | -341.00K | -2.69M |
| NetOtherInvestingChanges | -555.00K | |||
| NetInvestmentPurchaseAndSale | 0.00 | 0.00 | ||
| SaleOfInvestment | 0.00 | 0.00 | ||
| NetBusinessPurchaseAndSale | 0.00 | 250.00K | ||
| SaleOfBusiness | 0.00 | 250.00K | ||
| NetPPEPurchaseAndSale | -14.00K | -4.00K | -341.00K | -2.94M |
| PurchaseOfPPE | -14.00K | -4.00K | -341.00K | -2.94M |
| OperatingCashFlow | -3.88M | -8.97M | -70.41M | -146.67M |
| CashFlowFromContinuingOperatingActivities | -3.88M | -8.97M | -70.41M | -146.67M |
| ChangeInWorkingCapital | 867.00K | 4.73M | 6.02M | 10.58M |
| ChangeInOtherWorkingCapital | 434.00K | -2.48M | -1.86M | |
| ChangeInOtherCurrentLiabilities | -106.00K | -1.48M | -1.35M | -1.51M |
| ChangeInPayablesAndAccruedExpense | 5.28M | 5.05M | -2.11M | 3.61M |
| ChangeInAccruedExpense | 6.18M | 961.00K | -6.58M | 3.61M |
| ChangeInPayable | -910.00K | 4.09M | 4.47M | -4.00K |
| ChangeInAccountPayable | -910.00K | 4.09M | 4.47M | -4.00K |
| ChangeInPrepaidAssets | -265.00K | 3.66M | 2.59M | 13.88M |
| ChangeInInventory | 57.00K | 2.11M | 1.57M | -21.00K |
| ChangeInReceivables | -4.09M | -4.61M | 5.32M | -5.38M |
| ChangesInAccountReceivables | -4.09M | -4.61M | 5.32M | -5.38M |
| OtherNonCashItems | 3.08M | 1.80M | 3.24M | 4.07M |
| StockBasedCompensation | 847.00K | 1.19M | 3.31M | 8.90M |
| UnrealizedGainLossOnInvestmentSecurities | -3.70M | -4.88M | -106.95M | 33.66M |
| ProvisionandWriteOffofAssets | 1.58M | -300.00K | 300.00K | |
| AssetImpairmentCharge | 63.00K | 1.58M | ||
| DepreciationAmortizationDepletion | 756.00K | 1.78M | 2.05M | 1.02M |
| DepreciationAndAmortization | 756.00K | 1.78M | 2.05M | 1.02M |
| AmortizationCashFlow | 619.00K | 0.00 | ||
| AmortizationOfIntangibles | 619.00K | 0.00 | ||
| Depreciation | 137.00K | 1.78M | 2.05M | 1.02M |
| OperatingGainsLosses | 3.06M | -68.15M | 98.92M | |
| GainLossOnInvestmentSecurities | 3.30M | 6.78M | 72.99M | |
| NetForeignCurrencyExchangeGainLoss | 0.00 | 514.00K | 0.00 | |
| GainLossOnSaleOfPPE | 734.00K | 2.51M | 926.00K | 0.00 |
| NetIncomeFromContinuingOperations | -8.86M | 52.98M | -76.70M | -205.19M |
SEC Filings
Recent 10-K, 10-Q, 8-K, and Form 4 (insider) filings.
Public Trades for EVFM
| Date | User | Asset | Broker | Type | Position Size | Entry Price | Patterns |
|---|